3rd Quarter - Report

MR. BRIAN KELLY for TAKEDA PHARMACEUTICAL COMPANY

Period 3rd Quarter 2025 Filed Oct 16, 2025 Signed by Brian Kelly

Official filing
Firm
MR. BRIAN KELLY
Client
TAKEDA PHARMACEUTICAL COMPANY
Income
$10,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Trade and tariffs

LobbyistCovered position, as disclosed
BRIAN L KELLY —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); White House Office

Tariff (miscellaneous tariff bills) TAR

Government tariffs on drug imporatation.

LobbyistCovered position, as disclosed
BRIAN L KELLY —

Contacted: U.S. Trade Representative (USTR); White House Office

Trade (domestic/foreign) TRD

Trade/Tariffs on drug pricing and importation

LobbyistCovered position, as disclosed
BRIAN L KELLY —

Contacted: White House Office; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Taxation/Internal Revenue Code TAX

tax issues related to drugs and pricing

LobbyistCovered position, as disclosed
BRIAN L KELLY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.